Violette Shelia M.
Chief Scientific Officer
Violette Shelia M. has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Oct 14, 2026.
On the most recent filing, Violette Shelia M. is listed as Chief Scientific Officer at Q32 Bio Inc. Inside the rolling window, Violette Shelia M. reported no open-market purchases and 3 open-market sales totaling $67K in QTTB. The largest disclosed transaction in the window is a sale of 2,798 QTTB shares on Aug 25, 2026, worth $46K.
Companies traded
Other insiders at QTTB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$67K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Violette Shelia M. made?
Violette Shelia M. has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Violette Shelia M. trade?
Violette Shelia M. has filed SEC Form 4 disclosures for 1 company, including QTTB.
When was Violette Shelia M.'s most recent SEC Form 4 filing?
Violette Shelia M.'s most recent SEC Form 4 filing on Tracefour is dated Oct 14, 2026.
What is Violette Shelia M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Violette Shelia M. is listed as Chief Scientific Officer.
What is Violette Shelia M.'s total buy and sell value in the current window?
Inside the rolling retention window, Violette Shelia M. bought $0 and sold $67K based on SEC Form 4 filings.
What was Violette Shelia M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,798 QTTB shares on 2026-08-25, worth $46K, per SEC Form 4 filings.